Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
11418 | 917 | 22.7 | 52% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
668 | 12550 | NASOPHARYNGEAL CARCINOMA//EPSTEIN BARR VIRUS//EBV |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | INFECTIOUS MONONUCLEOSIS | Author keyword | 43 | 29% | 13% | 123 |
2 | MONONUCLEOSIS | Author keyword | 6 | 33% | 2% | 16 |
3 | ACUTE EBV INFECTION | Author keyword | 3 | 100% | 0% | 3 |
4 | GLANDULAR FEVER | Author keyword | 2 | 44% | 0% | 4 |
5 | ESPTEIN BARR VIRUS | Author keyword | 2 | 67% | 0% | 2 |
6 | EPSTEIN BARR VIRUS INFECTION | Author keyword | 2 | 16% | 1% | 12 |
7 | EPSTEIN BARR VIRUS SEROLOGY | Author keyword | 2 | 50% | 0% | 3 |
8 | VIRAL CAPSID ANTIGEN | Author keyword | 2 | 43% | 0% | 3 |
9 | AGE SPECIFIC EBV ANTIBODY PREVALENCE | Author keyword | 1 | 100% | 0% | 2 |
10 | CHRONIC EPSTEIN BARR VIRUS INFECTION | Author keyword | 1 | 50% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MONONUCLEOSIS | 27 | 20% | 13% | 122 |
2 | HETEROPHIL ANTIBODY | 18 | 89% | 1% | 8 |
3 | INFECTIOUS MONONUCLEOSIS | 13 | 12% | 11% | 102 |
4 | IN WONDERLAND SYNDROME | 3 | 60% | 0% | 3 |
5 | CELL COUNT RATIO | 2 | 67% | 0% | 2 |
6 | PRIMARY EBV INFECTION | 1 | 31% | 0% | 4 |
7 | HETEROPHILE ANTIBODY | 1 | 38% | 0% | 3 |
8 | BARR VIRUS ENCEPHALITIS | 1 | 50% | 0% | 2 |
9 | DIFFUSE PNEUMONIA | 1 | 100% | 0% | 2 |
10 | INFECTIOUS MONONUCLEOSIS HEPATITIS | 1 | 100% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Routine Epstein-Barr virus diagnostics from the laboratory perspective: Still challenging after 35 years | 2004 | 77 | 23 | 65% |
Current diagnosis and management of infectious mononucleosis | 2012 | 14 | 22 | 45% |
Antiviral treatment for severe EBV infections in apparently immunocompetent patients | 2010 | 13 | 47 | 74% |
Acute complications of Epstein-Barr virus infectious mononucleosis | 2000 | 60 | 44 | 43% |
The Neuroanatomic Localization of Epstein-Barr Virus Encephalitis May Be a Predictive Factor for Its Clinical Outcome: A Case Report and Review of 100 Cases in 28 Reports | 2009 | 11 | 22 | 64% |
Epstein-Barr virus infectious mononucleosis | 2001 | 27 | 16 | 69% |
Mononucleosis and athletic participation: An evidence-based subject review | 2008 | 20 | 43 | 35% |
Characteristic MR features of encephalitis caused by Epstein-Barr virus: a case report | 1998 | 16 | 2 | 100% |
Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections | 2011 | 42 | 167 | 18% |
Epstein-Barr Virus | 2011 | 6 | 9 | 67% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | COMPREHENS INFECT | 1 | 50% | 0.1% | 1 |
2 | HEAD OTOLARYNGOL HEAD NECK SURG | 1 | 50% | 0.1% | 1 |
3 | HEMATONCOL UNIT | 1 | 50% | 0.1% | 1 |
4 | HOP GUSTAVE DRON | 1 | 50% | 0.1% | 1 |
5 | MED KLIN ONKOL 4 | 1 | 50% | 0.1% | 1 |
6 | MED LINEBERGER COMPREHENS CANC | 1 | 50% | 0.1% | 1 |
7 | MIKROBIOL ANABILIM DALI | 1 | 50% | 0.1% | 1 |
8 | OFTALMOL IRMANDADE | 1 | 50% | 0.1% | 1 |
9 | PEOPLES HOSP HANGZHOU 6 | 1 | 50% | 0.1% | 1 |
10 | REGULATORY MED AFFAIRS | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000163611 | CEREBELLITIS//ACUTE CEREBELLAR ATAXIA//HEMICEREBELLITIS |
2 | 0.0000122441 | SLAM ASSOCIATED PROTEIN SAP//ANTI CMV ANTIBODIES//VARICELLA ARTHRITIS |
3 | 0.0000121078 | SPONTANEOUS SPLENIC RUPTURE//SPLENIC RUPTURE//SPLEEN RUPTURE |
4 | 0.0000110127 | POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER//PTLD//POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE |
5 | 0.0000097118 | AUSTRALIAN VACCINE DEV TUMOUR IMMUNOL//EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 1//JOINT ONCOL PROGRAM |
6 | 0.0000090533 | XLP//2B4//X LINKED LYMPHOPROLIFERATIVE DISEASE |
7 | 0.0000089276 | BZLF1//BRLF1//VIRAL MOL TUMOR DIAGNOST UNIT |
8 | 0.0000064231 | HERPES SIMPLEX ENCEPHALITIS//HERPES SIMPLEX VIRUS ENCEPHALITIS//ENCEPHALITIS |
9 | 0.0000051667 | FLUOROSCEIN ISOTHIOCYANATE//INFLUENZA A H1N12009//LUCIFER YELLOW CARBOHYDRAZIDE |
10 | 0.0000051210 | LYMPHOEPITHELIOMA LIKE CARCINOMA//LYMPHOEPITHELIOMA//LYMPHOEPITHELIAL CARCINOMA |